Clinical trials: Metastatic Malignant Neoplasm to Brain
Brain Metastasis
Study of Whole-brain Irradiation With Chloroquine for Brain Metastases
Background and purposes:Chloroquine (CLQ), an antimalarial drug, has a lysosomatrophic effect associate with increase the sensibility of Radiation through leakage of hidroliticenzimes, increase of apoptosis, autophagy mediated by…
- Trial name
- CLQ (NCT01894633)
- Testing
- Chloroquine, Total brain radiotherapy
- Where
- Mexico
- Volunteers
- 73 people
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
NSCLC
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
The purpose of this study is to evaluate the safety profile and efficacy of whole brain radiotherapy (WBRT) concomitantly with temozolomide (TMZ) in patients with brain metastases (BM).Patients with BM were randomly assigned to…
- Trial name
- NCT02385136
- Testing
- Temozolomide
- Volunteers
- 135 people
- Sponsor
- Zhejiang Cancer Hospital
Carcinoma, Non-Small-Cell Lung
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.
The purpose of this study is to learn about dacomitinib for the possible treatment of lung cancer which has spread to other parts of the body.
- Trial name
- NCT06075615
- Testing
- dacomitnib
- Sponsor
- Pfizer
Metastases to Brain
Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning
With this project, the study group wants to investigate whether a postoperative navigated transcranial magnetic stimulation (nTMS) motor map can improve stereotactic radiosurgery (SRS) planning in patients who underwent resection…
- Trial name
- MENTOR (NCT07415668)
- Testing
- Navigated Transcranial Magnetic Stimulation (nTMS)
- Where
- Switzerland
- Volunteers
- 30 people
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Cytomegalovirus Infections
Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy
Radio(chemo)therapy is the standard therapy for both, brain tumors and brain metastases. Neurological decline is observed in these patients and tumor progression or radiotherapy side effects have been made responsible for this.
- Trial name
- GLIO-CMV-01 (NCT02600065)
- Testing
- Blood draw and MRI
- Where
- Germany
- Volunteers
- 350 people
- Sponsor
- University of Erlangen-Nürnberg Medical School
NSCLC, Non-small Cell Lung Cancer
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
Investigating potential of controlling brain metastases in patients with EGFR positive NSCLC.
- Trial name
- NCT03535363
- Testing
- Osimertinib
- Where
- 2 sites in United States
- Volunteers
- 6 people
- Sponsor
- Case Comprehensive Cancer Center
Advanced Cancer, Brain Metastases
DM-CHOC-PEN for Brain Tumors in AYA Subjects
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a polychlorinated pyridyl cholesterol carbonate that is lipophilic, electrically neural, crosses the blood brain barrier (BBB), ability to localize in intracranial…
- Trial name
- NCT03668847
- Testing
- DM-CHOC-PEN
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- DEKK-TEC, Inc.
Dementia, Chronic Disease
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
The objective of this protocol is to test the effectiveness of a Jumpstart intervention on patient-centered outcomes for patients with chronic illness by ensuring that they receive care that is concordant with their goals over…
- Conditions
- Dementia, Chronic Disease, Neoplasm Metastasis, Lung Neoplasm
- Trial name
- PICSI-H (NCT04281784)
- Testing
- EHR-based Clinician Jumpstart
- Where
- 3 sites in United States
- Volunteers
- 2,512 people
- Sponsor
- University of Washington
Metastatic Malignant Neoplasm to Brain, Recurrent Brain Metastases
Palbociclib and Pembrolizumab In Central Nervous System Metastases
This research study is studying This research study is studying the efficacy and safety of the following study drugs as a possible treatment for recurrent central nervous system (CNS) metastases: Palbociclib alone (Cohort 1) The…
- Conditions
- Metastatic Malignant Neoplasm to Brain, Recurrent Brain Metastases, Progressive Brain Metastases
- Trial name
- NCT02896335
- Testing
- Palbociclib, Pembrolizumab
- Where
- 2 sites in United States
- Volunteers
- 45 people
- Sponsor
- Massachusetts General Hospital
ALK-positive Non-small Cell Lung Cancer, Brain Metastases
A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis
This study was a retrospective observational study. The study included patients with non-small cell lung cancer with ALK-fusion brain metastases or meningeal metastases who received first-line and late-line treatment with the…
- Conditions
- ALK-positive Non-small Cell Lung Cancer, Brain Metastases, Meningeal Metastasis
- Trial name
- NCT06410040
- Testing
- Lorlatinib
- Where
- China
- Volunteers
- 28 people
- Sponsor
- Sichuan Cancer Hospital and Research Institute
Brain Metastases, Non Small Cell Lung Cancer
SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer
This trial is a randomized, 2-arm, phase II study to determine the effect, if any, of the timing of stereotactic radiosurgery (SRS) relative to immune checkpoint inhibitor (IO) therapy in patients with non-small cell lung cancer…
- Trial name
- STICk-IM-NSCLC (NCT04650490)
- Testing
- Stereotactic Radiosurgery, Immunotherapy
- Where
- United States
- Sponsor
- Duke University
Recurrent Grade 4 Glioma, Brain Metastases From Extra-cranial Solid Tumors
Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using Microbubble-Enhanced Sonication
CAMPSIS is a preliminary feasibility study of the TheraOne medical device (IIb). TheraOne is an active, non-invasive medical device intended to deliver transcranial FUS in combination with intravenous microbubbles in order to…
- Trial name
- CAMPSIS (NCT07754006)
- Testing
- Temporarily and locally induce permeability of the blood-brain barrier (sonication) using TheraOne
- Where
- France
- Volunteers
- 6 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
Brain Metastases, Adult
Brain Imaging Biomarkers in Patients With Brain Metastasis
A biomarker is a measurable indicator of the severity or presence of some disease state. In this study, brain metastases patients who will be receiving radiation treatment, will undergo CT (Computed Tomography) and MRI (Magnetic…
- Trial name
- NCT04197297
- Testing
- CT and MRI Scans
- Where
- Canada
- Volunteers
- 90 people
- Sponsor
- University Health Network, Toronto
Breast Cancer With Brain Metastasis, HER2-low Expressing Breast Cancer
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
A phase II, open-label, multicenter, randomized controlled trial exploring the efficacy and safety of Trastuzumab Deruxtecan combined with or without Bevicizumab in HER2-low breast cancer with brain metastasis.
- Trial name
- THUMB (NCT07150208)
- Testing
- Bevacizumab (Bev), Trastuzumab Deruxtecan (T-DXd)
- Where
- China
- Volunteers
- 140 people
- Sponsor
- Fudan University
Melanoma, Brain Metastasis
Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases
This is a non-controlled, open label, Phase II Study of ipilimumab combined with a Stereotactic Radiosurgery. The study included an induction phase of four IV infusions of Ipilimumab at 10 mg/kg every 3 weeks associated with a…
- Trial name
- IPI+RTS (NCT02662725)
- Testing
- IPILIMUMAB, Stereotactic radiosurgery
- Where
- 18 sites in France
- Volunteers
- 73 people
- Sponsor
- University Hospital, Lille
Brain Metastases
Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC
This study evaluates hippocampus-sparing whole-brain radiotherapy with simultaneous integrated boost for patients with multiple brain metastases from non-small cell lung cancer.
- Trial name
- KROG17-06 (NCT03366376)
- Testing
- WBRT with hippocampus-sparing and SIB
- Where
- South Korea
- Volunteers
- 80 people
- Sponsor
- Samsung Medical Center
Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma
Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
Hyperosmotic agents are used to decrease intracranial pressure. The aim of the study is to compare the effects of continuous 3% hypertonic saline (HS), bolus HS and 20% mannitol on intraoperative brain relaxation in patients with…
- Trial name
- NCT04314674
- Testing
- %3 HS bolus, %3 HS infusion 20 ml/h, 20% mannitol
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Istanbul University
Lung Neoplasm, Brain Metastases
HA-WBRT-SIB for Brain Metastasis of Lung Cancer
Patients with lung cancer and brain metastases undergo HA-WBRT-SIB using image-guided radiotherapy, receiving a total dose of 30-36 Gy delivered in 18-20 fractions to the whole brain (CTV), while the dose to the GTV is boosted to…
- Conditions
- Lung Neoplasm, Brain Metastases, Simultaneous Integrated Boost, Hippocampal Avoidance
- Trial name
- NCT06289023
- Testing
- HA-WBRT-SIB
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Brain Metastases, Radiosurgery
Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis
This trial uses multi-parametric magnetic resonance imaging (MRI) to develop and validate imaging risk score to predict radiation necrosis in participants with brain metastasis treated with radiation therapy.
- Trial name
- NCT05868928
- Testing
- Magnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling (ASL)
- Where
- South Korea
- Volunteers
- 132 people
- Sponsor
- Asan Medical Center
Neoplasm Metastasis
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
This study is to look more closely at the tumor removed during your surgery, and to follow your condition after your treatment. The purpose of this study is to determine what side effects are common or more rare from this…
- Trial name
- NCT00904553
- Testing
- Novalis Shaped Beam Surgery
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- University of Rochester
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.